CPS | combined positive score |
EMA | European Medicine Agency |
FDA | Food and Drug Administration |
HNSCC | head and neck squamous cell carcinoma |
NSCLC | non–small cell lung cancer |
OS | overall survival |
PD-1 | programmed death-1 |
PD-L1 | programmed death ligand 1 |
PFS | progression-free survival |
R/M | recurrent/metastatic |
TAM | tumor-associated macrophage |
TIL | tumor-infiltrating lymphocyte |
TPS | tumor proportion score |